which of those biological products are to be included in the Union antigen, vaccine and diagnostic reagent banks and for which of the listed diseases referred to in point (a) of Article 9(1);
na táirgí bitheolaíocha atá le háireamh i mbainc antaiginí, vacsaíní agus imoibrithe diagnóiseacha an Aontais agus na galair liostaithe dá dtagraítear i bpointe (a) d'Airteagal 9(1) a gcomhfhreagraíonn siad dóibh;